The Landscape of Drug Sensitivity and Resistance in Sarcoma

Investigators leveraged patient-derived tumor organoids to characterize the landscape of drug resistance and sensitivity in sarcoma, collecting 194 specimens from 126 patients spanning 24 distinct sarcoma subtypes.